The effect of switching from ribociclib to palbociclib due to toxicity in hormone receptor-positive, HER2-negative metastatic breast cancer: a real-world, multicenter, retrospective study
Authors: Ahmet Oruç, İlknur Deliktaş Onur, Galip Can Uyar et al.
Publication: Scientific Reports
Published: Mar 26, 2026
Source: Crossref